Hyaluronic Acid for Knee Arthritis Fascinates Me as a Sports Medicine Doctor

If there is one topic in sports and exercise medicine that I could happily talk about for hours, it's hyaluronic acid injections for knee arthritis.

That might sound a little odd.

After all, knee arthritis is one of the most common conditions I see in clinic. Surely we already know what works and what doesn't?

The reality is far more interesting than that.

Over the years, I have seen people gain very little benefit from hyaluronic acid injections.

I've also seen people who had stopped walking hills, stopped playing golf, struggled on holiday, given up running, or found themselves becoming increasingly restricted by knee pain regain confidence, activity and independence following treatment.

Does that mean hyaluronic acid is a miracle cure?

Absolutely not.

But it does raise an interesting question:

Why do some people seem to benefit so much, while others don't appear to respond at all?

For me, that's one of the most interesting questions in modern osteoarthritis treatment.

Why Are Patients So Confused About Hyaluronic Acid?

If you've researched hyaluronic acid online, you've probably discovered completely conflicting opinions.

Some clinics describe it as an excellent treatment for arthritis.

Others suggest it doesn't work.

Some patients discover that NICE does not recommend routine use of hyaluronic acid injections and wonder why any doctor would offer them at all.

So who's right?

The answer is that different expert organisations have reviewed much of the same evidence and reached different conclusions.

That doesn't necessarily mean one group is right and another is wrong.

More often, it means they are asking different questions.

First of All, What Is NICE?

Most patients have never heard of NICE.

NICE stands for the National Institute for Health and Care Excellence. It produces guidance used throughout the NHS.

Importantly, NICE does not simply ask:

"Can this treatment help some patients?"

NICE must also ask:

"Should this treatment be routinely offered across an entire healthcare system?"

That means NICE considers:

• Clinical effectiveness

• Safety

• Value for money

• Consistency of results

• NHS resources

• Population-level outcomes

  
  

In other words, NICE focuses on what is best for large populations of patients.

In its current osteoarthritis guidance, NICE does not recommend routine use of hyaluronic acid injections.

Viewed from the perspective of national healthcare planning and population medicine, that is an entirely reasonable position.

Why Do Other Expert Groups Reach Different Conclusions?

This is where things become particularly interesting.

As of 2026, not all expert organisations agree with NICE.

Several international groups continue to support a role for hyaluronic acid in carefully selected patients with symptomatic knee osteoarthritis.

These include:

Organisation	General Position
NICE (UK)	Does not recommend routine use
OARSI (Osteoarthritis Research Society International)	Supports use in selected patients
ESSKA (European Society of Sports Traumatology, Knee Surgery and Arthroscopy)	Generally supportive in selected patients
EUROVISCO	Supportive in carefully selected patients

Patients often find it surprising that respected organisations can examine similar evidence and reach different conclusions.

The reason is that they are often asking different questions.

NICE may ask:

"Should everyone with knee arthritis routinely receive this treatment?"

Sports medicine and arthritis specialists often ask:

"Could this treatment help a carefully selected patient who remains symptomatic despite appropriate first-line treatment?"

Those are not the same question.

And that distinction is incredibly important.

The Question That's Changing Everything

For years, the debate focused on a seemingly simple question:

Does hyaluronic acid work?

Increasingly, I think it is only part of the question.

If every patient improved dramatically, there would be no debate.

If nobody improved, there would be no debate.

The fact that some patients appear to achieve substantial benefit while others achieve little benefit is exactly why the discussion continues.

The more interesting question is:

Which patients are most likely to benefit?

That is where much of the current research and discussion is moving.

And in my view, it's a far more useful question for patients.

What Does the Evidence Actually Show?

This is where many articles become overly simplistic.

The evidence is neither overwhelmingly positive nor overwhelmingly negative.

The reality sits somewhere in the middle.

Studies suggest that:

• Some patients experience little or no benefit.

• Some experience moderate improvements in pain and function.

• Some experience substantial improvements in pain, activity and quality of life.

  
  

That variation is one of the main reasons different guideline groups interpret the evidence differently.

Medicine would actually be much easier if every treatment either worked or didn't work.

Hyaluronic acid is fascinating because reality isn't that simple.

Why This Topic Interests Me So Much

One reason I enjoy discussing hyaluronic acid is that it reflects what I enjoy most about sports and exercise medicine.

Most patients don't fit neatly into guideline boxes.

They are individuals.

Different goals.

Different lifestyles.

Different sporting backgrounds.

Different expectations.

Different stages of arthritis.

Most of the patients I see are not looking for a miracle cure.

They are looking for ways to stay active.  For many people, arthritis isn't just about pain. It's about gradually giving up things that make life enjoyable.

They want to:

• Walk further

• Remain independent

• Enjoy holidays

• Continue hiking

• Keep playing golf

• Continue exercising

• Delay more invasive treatments if possible

  
  

Many have already worked hard with physiotherapy, strength training, exercise programmes and weight management strategies.

When someone asks me whether hyaluronic acid may be worth considering, the answer is rarely a simple yes or no.

And that's precisely what makes the topic so interesting.

Applying evidence thoughtfully to individuals is far more challenging, and far more rewarding, than simply following algorithms.

My Personal View

I don't believe every patient with knee arthritis should receive a hyaluronic acid injection.

I also don't believe hyaluronic acid should be dismissed simply because one guideline organisation interprets the evidence differently from another.

For me, the skill lies in patient selection.

The discussion shouldn't start with:

"Should everyone have hyaluronic acid?"

It should start with:

"Is this the right treatment for this particular person?"

That means considering:

• Symptoms

• Activity levels

• Severity of arthritis

• Previous treatments

• Personal goals

• Expectations

• Overall health

• The wider management plan

The injection itself is only one part of the picture.

Exercise remains important.

Strength remains important.

Weight management remains important.

Education remains important.

Good outcomes usually come from combining treatments thoughtfully rather than relying on a single intervention.

The Bottom Line

The debate around hyaluronic acid is not really about whether NICE is right or wrong.

NICE provides guidance for populations.

Sports medicine focuses on individuals.

My role is not to convince every patient to have an injection.

My role is to help patients understand where they fit within the evidence, what the uncertainties are, and whether hyaluronic acid is a treatment worth considering in their specific circumstances.

And if I'm honest, that's why I find this topic so fascinating.

Not because it is an injection.

Not because it is controversial.

But because it reminds us that good medicine is rarely about finding the right treatment

It’s about finding the right treatment for the right patient